Jonathan E Bard

14PUBLICATIONS
58CO-AUTHORS
Molecular targetsOral and maxillofacial surgeryHost-parasite interactionsCancer therapy (excl. chemotherapy and radiation therapy)Acoustics and noise control (excl. architectural acoustics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 13, 2026
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.

Surendra Gulla, Tej Sharma, Ephraim Gardner

|Oct 15, 2025
Multimodal Exploration Offers Novel Insights into the Transcriptomic and Epigenomic Landscape of the Human Submandibular Glands.

Erich Horeth, Theresa Wrynn, Jason M Osinski

|Jul 11, 2024
Life stage-specific poly(A) site selection regulated by <i>Trypanosoma brucei</i> DRBD18.

Jonathan E Bard, Brianna L Tylec, Ashutosh P Dubey

|Feb 17, 2024
Nuclear Factor I A and Nuclear Factor I B Are Jointly Required for Mouse Postnatal Neural Stem Cell Self-Renewal.

Christine E Campbell, Karstin Webber, Jonathan E Bard

|Jan 31, 2024
Mitochondrial ncRNA LDL-805 declines in alveolar epithelial type 2 cells of chronic obstructive pulmonary disease patients.

Theodore L Mathuram, Yafei Su, Jonathan E Bard

|Dec 01, 2023
Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid-derived suppressor cells.

Lixia Zhang, Kyu Hwan Kwack, Ramkumar Thiyagarajan

Pageof 3

Frequent Collaborators

3 joint publications

Donald Yergeau

3 joint publications

Natalie A Lamb

2 joint publications

Satrajit Sinha

1 joint publications

E Horeth